dexmedetomidine has been researched along with Cancer of Liver in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L; Fang, T; Li, TZ; Lin, L; Miao, HH; Shi, S; Ye, ZJ; Yu, KD | 1 |
| Liu, G; Ou, Y; Yang, Y; Yin, F; Zhang, F | 1 |
| Chen, P; Dai, G; Hong, J; Jiang, Y; Li, A; Lin, W; Luo, X; Luo, Y; Ning, X; Peng, S; Qu, C; Wang, H; Xie, P | 1 |
| Ding, Z; Fang, J; Fang, M; Fu, S; Guo, W; Wang, J; Wu, Q; Xiang, X; Xie, K; Yuan, X; Zhang, W; Zhou, H | 1 |
| Chen, HX; He, Y; Hei, Z; Jian, C; Li, X; Pan, J; Zhou, S | 1 |
| Guo, Z; Tian, ST; Xie, H; Yang, XL; Yu, HP; Zhang, FF | 1 |
| Aruga, Y; Hirano, M; Sakamaki, A; Tsubata, S; Yamakawa, M | 1 |
| Choi, SS; Jang, DM; Joung, KW; Kim, PN; Kong, YG; Lee, HM; Shim, JH; Shin, YM; Song, MH; Won, HJ | 1 |
| Harima, Y; Ikeda, K; Kariya, S; Komemushi, A; Kono, Y; Nakatani, M; Sano, A; Suzuki, S; Tanigawa, N; Utsunomiya, K; Yoshida, RY | 1 |
4 trial(s) available for dexmedetomidine and Cancer of Liver
| Article | Year |
|---|---|
[Protective effect of ulinastatin combined with dexmedetomidine against hepatic ischemia-reperfusion injury in laparoscopic hepatectomy for liver cancer and cirrhosis: a randomized controlled trial].
Topics: Dexmedetomidine; Hepatectomy; Humans; Interleukin-6; Laparoscopy; Liver Cirrhosis; Liver Neoplasms; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2022 |
Sedation and Analgesia for Liver Cancer Percutaneous Radiofrequency Ablation: Fentanyl and Oxycodone Comparison.
Topics: Aged; Analgesia; Analgesics, Opioid; Blood Pressure; Blood Pressure Determination; Conscious Sedation; Dexmedetomidine; Female; Fentanyl; Humans; Hypnotics and Sedatives; Liver Neoplasms; Male; Middle Aged; Oxycodone; Pain Measurement; Pain, Postoperative; Pain, Procedural; Radiofrequency Ablation; Respiration; Treatment Outcome | 2020 |
Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial.
Topics: Adult; Aged; Anesthesia, General; Carcinoma, Hepatocellular; Catheter Ablation; Dexmedetomidine; Female; Heart Rate; Humans; Liver Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Pain, Postoperative; Prospective Studies; Remifentanil; Sevoflurane | 2019 |
Comparative Effects of Dexmedetomidine and Propofol on US-Guided Radiofrequency Ablation of Hepatic Neoplasm Under Monitored Anesthesia Care: A Randomized Controlled Study.
Topics: Analgesics; Catheter Ablation; Dexmedetomidine; Female; Hemodynamics; Humans; Liver Neoplasms; Male; Piperidines; Propofol; Remifentanil | 2015 |
5 other study(ies) available for dexmedetomidine and Cancer of Liver
| Article | Year |
|---|---|
Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through α
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Carcinoma, Hepatocellular; Cardiovascular Physiological Phenomena; Dexmedetomidine; Humans; Hypoxia; Liver Neoplasms; Mice; Oxygen; Receptors, Adrenergic, alpha-2; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2022 |
Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chemokines; Dexmedetomidine; Disease Models, Animal; Disease Progression; Hepatic Stellate Cells; Humans; Interleukin-6; Liver Cirrhosis; Liver Neoplasms; Male; Mice, Inbred C57BL; Neoplasm Metastasis; Receptors, Adrenergic, alpha-2; STAT3 Transcription Factor | 2020 |
[Application of dexmedetomidine in radiofrequency ablation of liver tumor].
Topics: Adult; Dexmedetomidine; Humans; Hypnotics and Sedatives; Liver Neoplasms; Radiofrequency Ablation; Retrospective Studies | 2019 |
[Use of dexmedetomidine hydrochloride as a sedative during local therapy for hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Dexmedetomidine; Embolization, Therapeutic; Female; Humans; Hypnotics and Sedatives; Liver Neoplasms; Male; Middle Aged | 2015 |
[Feasibility and Safety of Dexmedetomidine Sedation in Transarterial Embolization for Hepatocellular Carcinoma with Hepatitis C-Related Cirrhosis].
Topics: Aged; Carcinoma, Hepatocellular; Dexmedetomidine; Embolization, Therapeutic; Feasibility Studies; Female; Hepatitis C; Humans; Hypnotics and Sedatives; Liver Cirrhosis; Liver Neoplasms; Male; Retrospective Studies | 2015 |